Ruffer LLP’s Soleno Therapeutics SLNO Stock Holding History

Ruffer LLP’s Portfolio SLNO Stock Details SLNO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-46,673	Closed	-$1.57M	–	212
2026 Q1	$1.57M	Buy	+46,673	New	+$1.83M	0.06%	157

Ruffer LLP's SLNO Position: Q2 2026 in Review

Ruffer LLP sold out of Soleno Therapeutics (SLNO) in Q2 2026, closing a stake of 46,673 shares — an estimated $1.57M sold.

Ruffer LLP first reported a position in SLNO in Q1 2026 and held it in 1 quarter. The position peaked at $1.57M in Q1 2026. 0 funds tracked by Wall St. Rank hold SLNO as of Q2 2026.

Ruffer LLP reported no remaining Soleno Therapeutics position as of Q2 2026 after selling out during the quarter.
Ruffer LLP sold 46,673 Soleno Therapeutics shares in Q2 2026, an estimated $1.57M.
Ruffer LLP first reported a position in Soleno Therapeutics in Q1 2026 and held it in 1 quarter.
Ruffer LLP's Soleno Therapeutics position peaked at $1.57M in Q1 2026.
0 funds tracked by Wall St. Rank held Soleno Therapeutics as of Q2 2026.

Based on Ruffer LLP's 13F filing for Q2 2026, filed 30 Jul 2026.